FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

Go back to FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
(NASDAQ: FBLG) Delayed: 0.81 +0.04 (5.19%)
Previous Close $0.77    52 Week High
Open $0.76    52 Week Low
Day High $0.82    P/E N/A 
Day Low $0.75    EPS
Volume 158,133